Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a type of blood cancer called CLL (Chronic Lymphocytic Leukaemia) and who are either being considered for, or have already received, a type of treatment known as a BTK inhibitor.
- People who have given their written agreement to take part in the study.
- People who are covered by a social security health insurance plan.
Who may not be able to join:
- People who are under 18 years of age.
- Adults who have a legal guardian making decisions on their behalf.
- People who have a protected legal status (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anne LOK, MD, PhD, Hospital of Nantes
Phone: 02.40.08.42.11
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Characterization of resistance mechanisms to CLL patients candidates or exposed to BTKd.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.